# AGAMREE
> **NDA215239** · New Drug Application · Sponsor: CATALYST PHARMS · Approved 2023-10-26
## Drug
- **FDA Application Number:** NDA215239
- **Application type:** New Drug Application
- **Brand name:** AGAMREE
- **Generic name:** VAMOROLONE
- **Active ingredients:** VAMOROLONE
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CATALYST PHARMS
- **Manufacturer:** Catalyst Pharmaceuticals, Inc.
- **First approval:** 2023-10-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215239)
---
*AI Analytics · CC0 1.0*